QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001

CompletedOBSERVATIONAL
Enrollment

595

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

December 2, 2021

Study Completion Date

December 2, 2021

Conditions
Meningitis/Encephalitis
Trial Locations (1)

Unknown

Qiagen, Manchester

All Listed Sponsors
lead

QIAGEN Gaithersburg, Inc

INDUSTRY

NCT05092438 - QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001 | Biotech Hunter | Biotech Hunter